Astera Labs, Inc.’s CEO Mohan Jitendra reported multiple open-market sales of Common Stock on May 7, 2026, totaling 139,951 shares. The transactions were executed by a living trust associated with him under a pre-arranged Rule 10b5-1 trading plan adopted on December 1, 2025.
Sale prices ranged around $199–$206 per share, reported as weighted averages across several trades. After these sales, the living trust still held 3,929,183 shares of Astera Labs Common Stock, while Jitendra also held additional shares directly and through several estate planning trusts.
Astera Labs director Stefan A. Dyckerhoff reported open-market sales totaling 12,499 shares of Common Stock on May 7, 2026. The shares were sold at weighted-average prices of $201.102 and $199.00 per share under a Rule 10b5-1 trading plan adopted on December 1, 2025.
After these sales, Dyckerhoff holds 65,361 shares directly and additional indirect positions, including 332,160 shares held by a trust and 6,278 shares held by a limited partnership, where he disclaims beneficial ownership except for his pecuniary interest.
Morgan Stanley Smith Barney LLC submitted a Form 144 reporting an affiliate's proposed sale of 40,000 shares of Common Stock of ALAB. The filing lists an aggregate amount of $8,556,400.00 and reports 171,407,939 shares outstanding as of 05/07/2026. The shares were acquired on 11/21/2017 via a Private Acquisition from Issuer or an Affiliate.
Morgan Stanley Smith Barney LLC reported an intent to sell 40,000 shares of Common stock of ALAB via a Form 144. The filing shows an aggregate amount of $8,556,400.00 and lists 171,407,939 shares outstanding as of 05/07/2026. The shares were acquired 11/21/2017 in a Private Acquisition from Issuer or an Affiliate.
Morgan Stanley Smith Barney LLC filed a Form 144 notice reporting proposed sale of 200,000 common shares of ALAB. The securities were originally acquired 11/21/2017 in a private acquisition from the issuer or an affiliate. The filing shows a NASDAQ listing and a filing date of 05/07/2026.
ALAB notice of proposed sales of common stock under Rule 144 by affiliated holders, reporting recent dispositions and holdings.
The excerpt lists two reported sales by Stefan A. Dyckerhoff of 11,599 shares on 04/17/2026 and 13,399 shares on 04/20/2026, with dollar values shown. It also lists a pro-rata distribution to Sutter Hill Ventures A California LP of 8,333 shares (related dates shown).
Lynch Desmond reported acquisition or exercise transactions in this Form 4 filing.
Astera Labs, Inc. Chief Financial Officer Desmond Lynch reported two equity awards of common stock. On May 1, 2026, he received grants classified as awards of restricted stock units (RSUs) under the company’s 2024 Stock Option and Incentive Plan.
One award for 7,083 RSUs vests 25% on February 15, 2027, with the remaining units vesting in 12 equal quarterly installments thereafter, subject to his continuous service. A second award for 42,501 RSUs vests 100% on February 15, 2027, also contingent on ongoing service. Each RSU represents the right to receive one share of Astera Labs common stock, and the transactions were recorded at a grant price of $0.00 per share, reflecting compensation rather than open-market buying.
Astera Labs delivered a very strong first quarter of 2026, combining rapid growth with high profitability. Revenue reached $308.4 million, up 93% from $159.4 million a year earlier, driven by higher demand and a richer mix of Scorpio, Aries, and Taurus products.
Gross margin improved to 76.3%, supported by favorable product mix. Operating income rose to $61.8 million, a 448% increase, and net income grew to $80.3 million, up 152% year over year. The company generated $74.6 million of operating cash flow and ended the quarter with $1.2 billion in cash, cash equivalents, and marketable securities, while total liabilities remained modest at $165.3 million.
Astera completed a $74.0 million acquisition of a data center acceleration business, adding technology and workforce and increasing goodwill to $87.7 million. Customer concentration remains high, with five customers each contributing at least 12% of revenue, primarily in Taiwan, Singapore, and China.
Astera Labs reported record Q1 2026 revenue of $308.4 million, up 14% sequentially and 93% year-over-year, driven by strong demand for its PCIe 6 connectivity portfolio. GAAP gross margin was 76.3%, with GAAP net income of $80.3 million and diluted EPS of $0.44.
On a non-GAAP basis, operating margin reached 36.2% and diluted EPS was $0.61. For Q2 2026, the company guides revenue to $355–$365 million, GAAP diluted EPS of $0.44–$0.46, and non-GAAP diluted EPS of $0.68–$0.70, indicating continued rapid growth in AI infrastructure demand.